Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Can SARS-Cov-2 be neutralized potently, using engineered ACE2 receptor traps?

Pfizer Life Science Manager Job Recruitment – Apply Online

Prediction of Survival Odds in COVID-19 by Zinc, Age and Selenoprotein P as Composite Biomarker

Can SARS-Cov-2 be neutralized potently, using engineered ACE2 receptor traps?
  • BiotechToday
  • World

Can SARS-Cov-2 be neutralized potently, using engineered ACE2 receptor traps?

bioxone October 24, 2020October 24, 2020

Ayooshi Mitra, Amity University, Kolkata

The crucial mechanism for severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and severe acute respiratory syndrome coronavirus 2  (SARS-CoV-2) infections initializes with the binding of the viral spike protein to angiotensin-converting enzyme II (ACE2) human receptor protein. In order to create a set of ACE2 variants optimized for affinity and also be enzymatically inactivated, a structured engineering approach was presented that was seen to strongly block SARS-CoV-2 cell infection.

These advanced receptors link tightly to the viral spike protein’s receptor-binding domain (RBD) and prevent entry into host cells. The ACE2-RBD interface was first computerized using a two-stage supple protein backbone design process that improved RBD affinity by up to 12 times. Through random mutagenesis and selection using yeast surface display, these designed receptor variants were made affinity matured of an additional 14-fold. Seven amino acid changes were present in the highest-affinity variant and bound to the RBD 170-fold more tightly than wild-type ACE2. With the adding of the natural ACE2 collection domain and fusion of the human immunoglobulin crystallizable fragment (Fc) domain for improved stabilization and specificity, the most efficient ACE2 receptor traps the neutralized SARS-CoV-2-pseudotype lentivirus and authentic SARS-CoV-2 virus with half-maximal inhibitory concentrations (IC50s) in the 10- to 100-ng / mL range. Orchestrated ACE2 receptor traps present a suitable route to combat SARS-CoV-2 and other coronavirus-using ACE2 infections, with the major benefit that viral resistance is also likely to damage viral entry. In addition, without the need for neutralizing antibodies isolated from convalescent patients, such traps can be pre-designed for viruses with known entry receptors for faster therapeutic response.

Also read: Blood glucose regulation by an organ-based multi-level model

References: Glasgow, Anum, Jeff Glasgow, Daniel Limonta, Paige Solomon, Irene Lui, Yang Zhang, Matthew A. Nix et al. “Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.” BioRxiv (2020). https://www.researcher-app.com/paper/6145549?deeplink=researcher://feed?paper_id%3D6145549

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Antibodies cell infection human receptor infection lentivirus mutagenesis receptor-binding domain SARS-CoV-1 SARS-CoV-2 severe acute respiratory syndrome viral protein

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Prediction of Survival Odds in COVID-19 by Zinc, Age and Selenoprotein P as Composite Biomarker

bioxone October 25, 2020

Poushalee Dey, Presidency University, Kolkata Zinc is one of the most important essential trace minerals in the human body. Its deficiency causes hypozincemia. Previously, some studies reported the positive effects of zinc and selenium supplements in the prevention and treatment of viral infections. A recent study evaluated the hypothesis of zinc and selenium deficiency in […]

Zinc

Related Post

  • BiotechToday
  • World

DeepHBV: A machine learning tool to aid in Hepatitis B integration site detection

BioTech Today July 9, 2021July 8, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University Machine learning has been useful to us in several ways. It has helped in the development of self-driving cars, google assistant, weather prediction, image recognition, language translation, you-tube recommendation, and much more. Machine learning finds it to be very helpful in biology, health informatics, and medical sciences […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

World TB Day 2021 – Let’s End TB: “The Clock is Ticking”

bioxone April 24, 2021April 24, 2021

Anuska Sen, Team BioXone The World Tuberculosis (TB) Day is commemorated on the 24th of April each year by the World Health Organization (WHO). This day is observed to spread public awareness about the life-threatening outcomes of tuberculosis disease and the need to adopt various methods to end the worldwide occurrence of TB. On the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India

COVAXIN : India’s preparation for massive vaccination drive.

bioxone January 10, 2021January 9, 2021

-Chitra Roy, University of Calcutta Covaxin, India’s indigenous COVID-19 vaccine, has been a subject of criticism due to its approval for restricted emergency use despite hot having published any phase 3 efficacy data. However, until recently, Bharat Biotech, the manufacturer of Covaxin claimed that its vaccine potentially generated safety data with the robust immune response […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy